Enhanced Cellular Entry and Efficacy of Tat Conjugates by Rational Design of the Auxiliary Segment

Citations Over TimeTop 10% of 2014 papers

Abstract

Conjugation with a cell penetrating peptide such as Tat presents an effective approach to improve the intracellular accumulation of molecules with low membrane permeability. This strategy, however, leads to a reduced cellular entry of molecules that can cross cell membrane effectively. We report here that covalent linkage of an additional hydrophobic unit that mimics a hydrophobic domain near the Tat sequence can further improve the cellular uptake of the parental conjugate into cancer cells regardless of the membrane permeability of the unconjugated molecule. Both fluorescent imaging and flow cytometry measurements confirmed the effect of palmitoylation on the increased internalization of the Tat conjugates with either 5-carboxyfluorescein (5-FAM), a nonmembrane penetrating dye, or doxorubicin, an anticancer cancer drug that can readily diffuse across cell membranes. In the case of the Tat-doxorubicin conjugate, palmitoylation improves the conjugate's anticancer activity in both drug sensitive and resistant cervical cancer cell lines. We further demonstrate that modification of a Tat-5-FAM conjugate with a hydrophobic quencher could not only efficiently quench the fluorescence outside of cancer cell but also facilitate its entry into MCF-7 breast cancer cells. These results highlight the importance of rational molecular design of using peptide conjugation chemistry in cancer therapeutics and diagnostics.

Related Papers

• → Studies of Reversible Conjugate Additions(2013)61 cited
• → Possible enhancing mechanisms for gene transfer activity of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate(2012)22 cited
• → Asymmetric conjugate addition reactions of allyl- and crotylstannanes(2003)22 cited
• → Effects of Some Auxins on IAA-Amino Acid Conjugate Formation in Carrot Tissues Transformed with Ti Plamids.(1993)2 cited
• [Preparation of an insulin conjugate with beta-galactosidase from E. coli for immunoenzyme assay].(1986)